Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 may cause temporary hair loss in some people.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

COVID-19 can cause hair and nail disorders after infection.

Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Androgenetic alopecia is the most common hair disorder, affecting more males, while telogen effluvium is more common in females, with stress and nutrition as key factors.

GLP-1RA therapy may increase the risk of hair loss.

Hair loss (telogen effluvium) happens before male pattern baldness.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

Teledermatology effectively diagnoses and manages non-scarring alopecia remotely.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Many young men with hair loss have low levels of vitamin D and B12.

Telogen effluvium is a common, distressing condition causing excessive hair shedding and has significant psychological effects on patients.

Trichoscopy is effective for diagnosing different types of non-scarring hair loss.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.